Your browser doesn't support javascript.
loading
Development of medical device software for the screening and assessment of depression severity using data collected from a wristband-type wearable device: SWIFT study protocol.
Kishimoto, Taishiro; Kinoshita, Shotaro; Kikuchi, Toshiaki; Bun, Shogyoku; Kitazawa, Momoko; Horigome, Toshiro; Tazawa, Yuki; Takamiya, Akihiro; Hirano, Jinichi; Mimura, Masaru; Liang, Kuo-Ching; Koga, Norihiro; Ochiai, Yasushi; Ito, Hiromi; Miyamae, Yumiko; Tsujimoto, Yuiko; Sakuma, Kei; Kida, Hisashi; Miura, Gentaro; Kawade, Yuko; Goto, Akiko; Yoshino, Fumihiro.
Afiliación
  • Kishimoto T; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
  • Kinoshita S; i2medical LLC, Kawasaki, Japan.
  • Kikuchi T; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
  • Bun S; Graduate School of Interdisciplinary Information Studies, The University of Tokyo, Tokyo, Japan.
  • Kitazawa M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Horigome T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Tazawa Y; Sato Hospital, Yamagata, Japan.
  • Takamiya A; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Hirano J; i2medical LLC, Kawasaki, Japan.
  • Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Liang KC; i2medical LLC, Kawasaki, Japan.
  • Koga N; Office for Open Innovation, Keio University, Tokyo, Japan.
  • Ochiai Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Ito H; Akasaka Clinic, Tokyo, Japan.
  • Miyamae Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Tsujimoto Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Sakuma K; i2medical LLC, Kawasaki, Japan.
  • Kida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Miura G; i2medical LLC, Kawasaki, Japan.
  • Kawade Y; Frontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan.
  • Goto A; Frontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan.
  • Yoshino F; Frontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan.
Front Psychiatry ; 13: 1025517, 2022.
Article en En | MEDLINE | ID: mdl-36620664
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Idioma: En Revista: Front Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Idioma: En Revista: Front Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Japón